Invesco’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-163,805
| Closed | -$4.8M | – | 3704 |
|
|
2017
Q3 | $4.8M | Buy |
163,805
+2,326
| +1% | +$65.2K | ﹤0.01% | 2010 |
|
|
2017
Q2 | $4.24M | Buy |
161,479
+9,472
| +6% | +$233K | ﹤0.01% | 2060 |
|
|
2017
Q1 | $3.56M | Buy |
152,007
+8,386
| +6% | +$207K | ﹤0.01% | 2221 |
|
|
2016
Q4 | $3.61M | Sell |
143,621
-9,078
| -6% | -$229K | ﹤0.01% | 2191 |
|
|
2016
Q3 | $4.29M | Buy |
152,699
+6,698
| +5% | +$172K | ﹤0.01% | 2079 |
|
|
2016
Q2 | $3.6M | Sell |
146,001
-54,347
| -27% | -$1.35M | ﹤0.01% | 2130 |
|
|
2016
Q1 | $4.43M | Sell |
200,348
-25,591
| -11% | -$681K | ﹤0.01% | 1957 |
|
|
2015
Q4 | $7.91M | Buy |
225,939
+599
| +0.3% | +$18.8K | ﹤0.01% | 1589 |
|
|
2015
Q3 | $6.42M | Buy |
225,340
+16,931
| +8% | +$569K | ﹤0.01% | 1696 |
|
|
2015
Q2 | $6.94M | Buy |
208,409
+60,980
| +41% | +$1.87M | ﹤0.01% | 1749 |
|
|
2015
Q1 | $4.16M | Sell |
147,429
-653,856
| -82% | -$16.3M | ﹤0.01% | 2105 |
|
|
2014
Q4 | $16.6M | Sell |
801,285
-453,124
| -36% | -$10.8M | 0.01% | 1270 |
|
|
2014
Q3 | $30.6M | Buy |
1,254,409
+178,257
| +17% | +$4.73M | 0.01% | 1020 |
|
|
2014
Q2 | $30.8M | Buy |
1,076,152
+895,010
| +494% | +$24.9M | 0.01% | 1031 |
|
|
2014
Q1 | $5.07M | Sell |
181,142
-73,850
| -29% | -$1.81M | ﹤0.01% | 1924 |
|
|
2013
Q4 | $5.48M | Buy |
254,992
+94,890
| +59% | +$1.72M | ﹤0.01% | 1945 |
|
|
2013
Q3 | $2.13M | Buy |
160,102
+24,320
| +18% | +$328K | ﹤0.01% | 2502 |
|
|
2013
Q2 | $1.88M | Buy |
+135,782
| New | +$1.92M | ﹤0.01% | 2426 |
|
Invesco's PMC Position: Q4 2017 in Review
Invesco sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 163,805 shares — an estimated $4.8M sold.
Invesco first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $30.8M in Q2 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Invesco reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Invesco sold 163,805 PharMerica Corporation shares in Q4 2017, an estimated $4.8M.
- Invesco first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Invesco's PharMerica Corporation position peaked at $30.8M in Q2 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Invesco's 13F filing for Q4 2017, filed 14 Feb 2018.